Efficacy and tolerability of once-daily 160 mg valsartan in Chinese patients with mild to moderate hypertension

The present multicentre, prospective, open-label, single treatment arm study (Val-Perfect) examined the efficacy and tolerability of once-daily valsartan monotherapy (80 mg for two weeks, followed by 160 mg for eight weeks) in 195 Chinese patients with mild to moderate hypertension, using office, ho...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Exp Ther Med
Main Authors: Sun, Ningling, Feng, Yingqing, Gao, Pingjin, Chen, Xiaoping, Qi, Litong, Zhang, Shuyang, Dong, Yugang, Yang, Xinchun, Li, Xinli, Chen, Yundai, Liu, Lingli
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2017
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403463/
https://ncbi.nlm.nih.gov/pubmed/28450950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2017.4051
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados